Register to chat with like-minded investors on our interactive forums.
The current 0Q1N market cap is 145.92B. The company's latest EPS is USD 1.4172 and P/E is 18.04.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 41.91B | 81.29B | 100.33B | 58.5B | 63.63B |
| Operating Income | 6.77B | 19.82B | 34.96B | -2.3B | 9.22B |
| Net Income | 9.62B | 21.98B | 31.37B | 2.12B | 8.03B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 154.23B | 181.48B | 197.21B | 226.5B | 213.4B |
| Total Liabilities | 90.76B | 104.01B | 101.29B | 137.21B | 124.9B |
| Total Equity | 63.47B | 77.46B | 95.92B | 89.29B | 88.5B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 14.4B | 32.58B | 29.27B | 8.7B | 12.74B |
| Investing | -4.27B | -22.55B | -15.78B | -32.28B | 2.65B |
| Financing | -9.65B | -9.82B | -14.83B | 26.07B | -17.14B |
| Market Cap | 145.92B |
| Price to Earnings Ratio | 18.04 |
| Price to Sales Ratio | 2.28 |
| Price to Cash Ratio | 138.91 |
| Price to Book Ratio | 1.64 |
| Dividend Yield | - |
| Shares Outstanding | 5.67B |
| Average Volume (1 week) | 35.77k |
| Average Volume (1 Month) | 108.27k |
| 52 Week Change | -6.70% |
| 52 Week High | 30.95 |
| 52 Week Low | 24.45 |
| Spread (Intraday) | 5.1 (18.15%) |
| Company Name | Pfizer Inc |
| Address |
235 east 42nd street new york, new york 10017 |
| Website | https://www.pfizer.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
